Research Article

Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart Failure

Table 3

Multivariate predictors of response to CD34+ cell therapy.

Variable coefficient value95% confidence interval
Lower boundUpper bound

%0.1220.220-0.0750.319
CKD-0.2010.120-0.4560.054
 pg/mL-0.2450.031-0.467-0.023
%-0.1210.330-0.3670.126
Galectin-3 decrease0.3060.0030.1130.498

LVEF: left ventricular ejection fraction; CKD: chronic kidney disease; RDW: red cell distribution width.